Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 12 studies | 25% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 1725.35 | 578 / 578 | 76% | 5.77 | 875 / 1155 |
uterus | 87% | 249.32 | 148 / 170 | 67% | 5.41 | 307 / 459 |
stomach | 89% | 396.22 | 319 / 359 | 60% | 3.84 | 173 / 286 |
kidney | 83% | 448.42 | 74 / 89 | 64% | 4.08 | 576 / 901 |
thymus | 97% | 703.37 | 635 / 653 | 48% | 24.80 | 289 / 605 |
breast | 88% | 334.12 | 404 / 459 | 50% | 3.79 | 564 / 1118 |
prostate | 94% | 477.62 | 230 / 245 | 42% | 1.91 | 209 / 502 |
liver | 92% | 366.12 | 208 / 226 | 38% | 2.38 | 154 / 406 |
intestine | 71% | 962.91 | 686 / 966 | 58% | 3.42 | 304 / 527 |
bladder | 76% | 467.29 | 16 / 21 | 51% | 3.46 | 258 / 504 |
skin | 58% | 152.39 | 1046 / 1809 | 60% | 8.01 | 284 / 472 |
esophagus | 59% | 180.84 | 853 / 1445 | 45% | 2.55 | 82 / 183 |
lymph node | 0% | 0 | 0 / 0 | 100% | 49.22 | 29 / 29 |
spleen | 100% | 5624.08 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 94% | 460.88 | 1135 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 5754.17 | 847 / 929 | 0% | 0 | 0 / 0 |
pancreas | 21% | 40.20 | 70 / 328 | 63% | 5.08 | 113 / 178 |
tonsil | 0% | 0 | 0 / 0 | 84% | 10.64 | 38 / 45 |
ovary | 41% | 93.31 | 73 / 180 | 26% | 1.00 | 112 / 430 |
adrenal gland | 44% | 86.66 | 114 / 258 | 13% | 0.46 | 29 / 230 |
blood vessel | 46% | 175.29 | 614 / 1335 | 0% | 0 | 0 / 0 |
heart | 43% | 99.38 | 370 / 861 | 0% | 0 | 0 / 0 |
brain | 29% | 51.76 | 770 / 2642 | 12% | 0.52 | 88 / 705 |
muscle | 18% | 28.90 | 142 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 14% | 0.87 | 11 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0050850 | Biological process | positive regulation of calcium-mediated signaling |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0045582 | Biological process | positive regulation of T cell differentiation |
GO_0045087 | Biological process | innate immune response |
GO_0070489 | Biological process | T cell aggregation |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0006955 | Biological process | immune response |
GO_0002250 | Biological process | adaptive immune response |
GO_0030217 | Biological process | T cell differentiation |
GO_0018108 | Biological process | peptidyl-tyrosine phosphorylation |
GO_0043366 | Biological process | beta selection |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0030154 | Biological process | cell differentiation |
GO_0046641 | Biological process | positive regulation of alpha-beta T cell proliferation |
GO_0042113 | Biological process | B cell activation |
GO_0045060 | Biological process | negative thymic T cell selection |
GO_0045059 | Biological process | positive thymic T cell selection |
GO_0006468 | Biological process | protein phosphorylation |
GO_0046638 | Biological process | positive regulation of alpha-beta T cell differentiation |
GO_0072678 | Biological process | T cell migration |
GO_0042110 | Biological process | T cell activation |
GO_0001772 | Cellular component | immunological synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0031234 | Cellular component | extrinsic component of cytoplasmic side of plasma membrane |
GO_0005911 | Cellular component | cell-cell junction |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0042101 | Cellular component | T cell receptor complex |
GO_0004715 | Molecular function | non-membrane spanning protein tyrosine kinase activity |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
GO_0001784 | Molecular function | phosphotyrosine residue binding |
Gene name | ZAP70 |
Protein name | Tyrosine-protein kinase ZAP-70 (EC 2.7.10.2) (70 kDa zeta-chain associated protein) (Syk-related tyrosine kinase) |
Synonyms | SRK |
Description | FUNCTION: Tyrosine kinase that plays an essential role in regulation of the adaptive immune response. Regulates motility, adhesion and cytokine expression of mature T-cells, as well as thymocyte development. Contributes also to the development and activation of primary B-lymphocytes. When antigen presenting cells (APC) activate T-cell receptor (TCR), a serie of phosphorylations lead to the recruitment of ZAP70 to the doubly phosphorylated TCR component CD247/CD3Z through ITAM motif at the plasma membrane. This recruitment serves to localization to the stimulated TCR and to relieve its autoinhibited conformation. Release of ZAP70 active conformation is further stabilized by phosphorylation mediated by LCK. Subsequently, ZAP70 phosphorylates at least 2 essential adapter proteins: LAT and LCP2. In turn, a large number of signaling molecules are recruited and ultimately lead to lymphokine production, T-cell proliferation and differentiation. Furthermore, ZAP70 controls cytoskeleton modifications, adhesion and mobility of T-lymphocytes, thus ensuring correct delivery of effectors to the APC. ZAP70 is also required for TCR-CD247/CD3Z internalization and degradation through interaction with the E3 ubiquitin-protein ligase CBL and adapter proteins SLA and SLA2. Thus, ZAP70 regulates both T-cell activation switch on and switch off by modulating TCR expression at the T-cell surface. During thymocyte development, ZAP70 promotes survival and cell-cycle progression of developing thymocytes before positive selection (when cells are still CD4/CD8 double negative). Additionally, ZAP70-dependent signaling pathway may also contribute to primary B-cells formation and activation through B-cell receptor (BCR). . |
Accessions | ENST00000708159.1 [P43403-2] ENST00000698508.1 [P43403-1] ENST00000264972.10 [P43403-1] P43403 ENST00000708154.1 [P43403-1] ENST00000451498.2 [P43403-2] ENST00000708152.1 [P43403-1] |